Facilitators and barriers to COVID-19 vaccine uptake among women in two regions of Ghana: A qualitative study.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2022
Historique:
received: 23 01 2022
accepted: 27 07 2022
entrez: 17 8 2022
pubmed: 18 8 2022
medline: 20 8 2022
Statut: epublish

Résumé

Although COVID-19 vaccines are available, evidence suggests that several factors hinder or facilitate their use. Several studies have found gender differences in COVID-19 vaccine uptake, with women less likely to vaccinate than men in many countries, including Ghana. These studies, however, have primarily been quantitative. This study used a qualitative approach to examine the facilitators and barriers to vaccine uptake among women in Ghana. Using a cross-sectional descriptive qualitative research design, 30 women in the Greater Accra and Ashanti regions of Ghana were conveniently sampled and interviewed using a semi-structured interview guide. Fifteen (15) interviews were conducted in each region. The data were transcribed verbatim and analysed thematically using QSR NVivo version 10 software. Among the key factors that facilitate COVID-19 vaccination are the desire to protect oneself and family against COVID-19, education about COVID-19 vaccines, seeing others receive the COVID-19 vaccine, and vaccine being cost-free. On the other hand, long queues at the vaccination centres, fear of side effects, misconceptions about the vaccines, and shortage of vaccines were the main barriers against COVID-19 vaccination. The study results show that individual, institutional, and vaccine-related factors facilitate or hinder COVID-19 vaccination among women. Addressing these factors need continuous comprehensive health education, and ensuring vaccine availability at vaccination sites will improve women's uptake of the COVID-19 vaccines.

Identifiants

pubmed: 35976969
doi: 10.1371/journal.pone.0272876
pii: PONE-D-22-02235
pmc: PMC9385066
doi:

Substances chimiques

COVID-19 Vaccines 0
Vaccines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0272876

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Vaccines (Basel). 2021 Aug 25;9(9):
pubmed: 34579185
BMJ. 2021 Mar 11;372:n699
pubmed: 33707182
Bull World Health Organ. 2021 Jan 01;99(1):19-33F
pubmed: 33716331
BMC Public Health. 2021 May 29;21(1):1017
pubmed: 34051770
Front Med (Lausanne). 2021 Oct 26;8:756275
pubmed: 34765623
PLoS One. 2021 Sep 24;16(9):e0257897
pubmed: 34559858
Am J Public Health. 2007 Apr;97(4):684-90
pubmed: 17329659
Biosecur Bioterror. 2013 Jun;11(2):96-106
pubmed: 23617721
J Public Health (Oxf). 2016 Dec 02;38(4):746-753
pubmed: 28158550
Vaccine. 2007 Jan 2;25(1):201-4
pubmed: 17011084
Lancet Public Health. 2021 Apr;6(4):e210-e221
pubmed: 33556325
J Nutr Health Aging. 2021;25(5):698-701
pubmed: 33949640
Hum Vaccin Immunother. 2015;11(10):2376-88
pubmed: 26110454
J Adv Nurs. 2019 Jun;75(6):1188-1206
pubmed: 30375040
Vaccine. 2019 Apr 24;37(18):2494-2501
pubmed: 30940484
J Public Health Policy. 2022 Mar;43(1):129-139
pubmed: 34983960
PLoS One. 2020 Dec 22;15(12):e0244420
pubmed: 33351852
Nat Rev Immunol. 2021 Oct;21(10):626-636
pubmed: 34373623
Vaccines (Basel). 2021 Aug 13;9(8):
pubmed: 34452025
Int J Infect Dis. 2021 May;106:376-381
pubmed: 33866000
Hum Resour Health. 2021 Nov 6;19(1):136
pubmed: 34742301
Isr J Health Policy Res. 2021 Mar 19;10(1):26
pubmed: 33741063
Pharm Pract (Granada). 2021 Jan-Mar;19(1):2317
pubmed: 33828623
Nat Med. 2021 Aug;27(8):1338-1339
pubmed: 34272500
Influenza Other Respir Viruses. 2021 May;15(3):361-370
pubmed: 33605010
Lancet Respir Med. 2021 Apr;9(4):e42-e43
pubmed: 33684355
Hum Vaccin Immunother. 2022 Dec 31;18(1):1-3
pubmed: 33684019
BMC Public Health. 2010 Mar 25;10:159
pubmed: 20338028
Glob Health J. 2021 Mar;5(1):51-55
pubmed: 33585053
Lancet. 2021 May 15;397(10287):1783-1785
pubmed: 33964221
Lancet. 2021 Mar 13;397(10278):1023-1034
pubmed: 33587887
J Multidiscip Healthc. 2020 Nov 20;13:1657-1663
pubmed: 33262600
Vaccines (Basel). 2021 Jul 22;9(8):
pubmed: 34451939
Res Nurs Health. 2010 Feb;33(1):77-84
pubmed: 20014004
Soc Sci Med. 2021 Mar;272:113638
pubmed: 33414032
PLoS One. 2020 May 6;15(5):e0232472
pubmed: 32374754
Pragmat Obs Res. 2020 Oct 29;11:103-109
pubmed: 33154695
Br Dent J. 2021 Jan;230(2):59
pubmed: 33483637
Vaccines (Basel). 2021 Dec 31;10(1):
pubmed: 35062720
Health Policy Plan. 2014 Oct;29(7):912-20
pubmed: 24107660
J Clin Med. 2021 Apr 01;10(7):
pubmed: 33916020
N Engl J Med. 2021 Aug 12;385(7):650-651
pubmed: 34289269
Hum Vaccin Immunother. 2021 Dec 2;17(12):5016-5023
pubmed: 34715002
Health Educ Res. 2011 Apr;26(2):192-200
pubmed: 21106651
Clin Exp Vaccine Res. 2021 May;10(2):183-190
pubmed: 34222131

Auteurs

Grace Frempong Afrifa-Anane (GF)

Department of Environment and Public Health, University of Environment and Sustainable Development, Somanya, Ghana.

Reuben Tete Larbi (RT)

Regional Institute for Population Studies, University of Ghana, Legon, Ghana.

Bright Addo (B)

Department of Sociology and Social Work, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.

Martin Wiredu Agyekum (MW)

Institute for Educational Research and Innovation Studies, University of Education, Winneba, Ghana.

Frank Kyei-Arthur (F)

Department of Environment and Public Health, University of Environment and Sustainable Development, Somanya, Ghana.

Margaret Appiah (M)

Department of Environment and Public Health, University of Environment and Sustainable Development, Somanya, Ghana.

Clara Opoku Agyemang (CO)

Regional Institute for Population Studies, University of Ghana, Legon, Ghana.

Ignatius Great Sakada (IG)

Department of Population, Family and Reproductive Health, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH